BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Press Releases

  MiNK Therapeutics to Provide Corporate Update and Second Quarter 2024 Financial Report

  August 1, 2024

   · 

  1 min read
• Press Releases

  FDA Recognizes Fibromyalgia as a ‘Serious Condition’ And Fast-Tracks New Drug Candidate

  August 1, 2024

   · 

  4 min read
• Press Releases

  Spinogenix Announces Open Enrollment for Phase 2 Study Evaluating SPG302 for the Treatment of Alzheimer’s Disease

  August 1, 2024

   · 

  3 min read
• Press Releases

  ViaDerma Finalizes Distribution Agreements in Dubai and Announces Six New Key Hires

  August 1, 2024

   · 

  2 min read
• Press Releases

  Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors

  August 1, 2024

   · 

  7 min read
• Press Releases

  enVVeno Medical Reports Second Quarter 2024 Financial Results and Provides Corporate Update

  August 1, 2024

   · 

  6 min read
• Press Releases

  Curis Provides Second Quarter 2024 Financial and Operating Update

  August 1, 2024

   · 

  13 min read
• Press Releases

  Corvus Pharmaceuticals Granted FDA Fast Track Designation for Soquelitinib for Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

  August 1, 2024

   · 

  6 min read
• Press Releases

  Mycovia Pharmaceuticals Announces Presentation of Results from Three Safety Studies Evaluating VIVJOA® (oteseconazole) in Subjects with Renal or Hepatic Impairment, and the Impact on QT Prolongation at the 2024 IDSOG Annual Meeting

  August 1, 2024

   · 

  6 min read
• Press Releases

  Resverlogix Announces Voting Results from the 2024 Meeting of Shareholders and Closing of Debenture Extension

  August 1, 2024

   · 

  3 min read